COMP <GO>
TDOC vs UNH // EV/EBITDA & P/E VALUATION
Teladoc Health Inc. (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: TDOC 3
— UNH 10
■ METRIC PARITY
LAST: $8.51 (-2.52%) • MKT CAP: $1.59B
valuation
—
LAST: $406.97 (-0.96%) • MKT CAP: $364.66B
valuation
16.4x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TDOC VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TDOC | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 88.57% | -47.57 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -17.00% | 11.47% | -28.47 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 16.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 18.00% | 6.48% | +11.52 | TDOC | /fcf-yield <GO> |
| Operating Margin | -10.40% | 4.82% | -15.22 | UNH | /operating-margins <GO> |
| Net Profit Margin | -7.90% | 3.14% | -11.04 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | -1.50% | 6.46% | -7.96 | UNH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.45 | 3.12 | -2.67 | UNH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.20% | 6.74% | +0.46 | UNH | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 77.7 | 56.0 | +21.64 | TDOC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.08 | 0.33 | +0.75 | TDOC | /macro-sensitivity <GO> |
| Forward P/E Multiple | 32.0x | 17.1x | +14.91 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.59B | $364.66B | -$363.07B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TDOC REV | UNH REV | TDOC GROSS % | UNH GROSS % | TDOC FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.53B | $447.57B | 44.0% | 88.7% | $285.5M | $16.07B |
| FY 2024 | $2.57B | $400.28B | 44.0% | 88.3% | $282.9M | $20.70B |
| FY 2023 | $2.60B | $371.62B | 44.0% | 89.6% | $232.9M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TDOC // BETA 1.08
UNH // BETA 0.33